KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Short term Debt (2020 - 2023)

Clover Health Investments (CLOV) has disclosed Short term Debt for 4 consecutive years, with $1.3 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Short term Debt fell 31.74% year-over-year to $1.3 million, compared with a TTM value of $1.3 million through Mar 2023, down 31.74%, and an annual FY2022 reading of $1.6 million, down 32.5% over the prior year.
  • Short term Debt was $1.3 million for Q1 2023 at Clover Health Investments, down from $1.6 million in the prior quarter.
  • Across five years, Short term Debt topped out at $20.8 million in Q4 2020 and bottomed at $1.3 million in Q1 2023.
  • Average Short term Debt over 4 years is $4.5 million, with a median of $1.7 million recorded in 2022.
  • The sharpest move saw Short term Debt plummeted 88.85% in 2021, then tumbled 31.74% in 2023.
  • Year by year, Short term Debt stood at $20.8 million in 2020, then tumbled by 88.85% to $2.3 million in 2021, then tumbled by 32.5% to $1.6 million in 2022, then decreased by 15.01% to $1.3 million in 2023.
  • Business Quant data shows Short term Debt for CLOV at $1.3 million in Q1 2023, $1.6 million in Q4 2022, and $1.7 million in Q3 2022.